476322-70-0COc1ccc(CN2CCN(c3ccc(Br)c(OC)n3)CC2)cc1OCVAKYVNYLCIABRV-UHFFFAOYSA-NNGD-4715 is an investigational compound developed for the treatment of Obesity. NGD-4715 functions as a melanin-concentrating hormone receptor 1 antagonist.
476322-70-0DTXSID10432090NGD-4715 works as a small molecule antagonist at the melanin concentrating hormone receptor-1 (MCHR1). Neurogen’s obesity program has focused on blocking the melanin concentrating hormone receptor-1 (MCH1). Reported studies in rodents support MCH being an important mediator of caloric intake. Deletion of MCH or the MCH1 receptor gene resulted in lean animals, while over-production of MCH caused increased weight gain. Neurogen’s studies indicated that selectively blocking MCH1 was sufficient to achieve a significant reduction in food intake in a higher animal species.
VerwendenNGD 4715, is a selective and orally active melanin-concentrating hormone receptor 1 (MCHR1) antagonist .
Wird geladen…